Mylan, Pfizer Want EpiPen Row Paused For Class Cert. Appeal
Mylan and Pfizer asked a Kansas federal court to pause a class action accusing the drugmakers of scheming to inflate prices of the emergency allergy treatment EpiPen while they try to...To view the full article, register now.
Already a subscriber? Click here to view full article